Skip to main content
. 2017 Apr 16;2017(4):CD012633. doi: 10.1002/14651858.CD012633
# Searches
1 exp ERYTHROPOIETIN/
2 erythropoietin.mp.
3 erythropoiesis.mp.
4 exp EPOETIN ALFA/
5 epoetin.mp.
6 epo.mp.
7 epoetin alfa.mp.
8 epoetin beta.mp.
9 eprex.mp.
10 neorecormon.mp.
11 aranesp.mp.
12 procrit.mp.
13 recombinant erythropoietin.mp.
14 darbepoetin alfa.mp.
15 darbepoetin.mp.
16 RECEPTORS, ERYTHROPOIETIN/
17 CERA.mp.
18 epoetin theta.mp.
19 epoetin zeta.mp.
20 silapo*.tw,kf,nm,ot.
21 retacrit*.tw,kf,nm,ot.
22 biopoin*.tw,kf,nm,ot.
23 eporatio*.tw,kf,nm,ot.
24 or/1‐23
25 anaemia.mp.
26 anemia.mp.
27 (anemi* adj3 cancer).mp.
28 (anaemi* adj3 cancer).mp.
29 or/25‐28
30 ANEMIA, IRON‐DEFICIENCY/
31 IRON/
32 IRON COMPOUNDS/
33 iron*.sh.
34 iron*.tw,kf,ot.
35 ferri*.tw,kf,ot.
36 (ferro* adj2 (compound* or compund*)).tw,kf,ot.
37 hemosider*.tw,kf,ot.
38 sideros*.tw,kf,ot.
39 transferrin*.tw,kf,ot.
40 or/30‐39
41 exp NEOPLASMS/
42 malignan*.mp.
43 cancer*.mp.
44 oncolog*.tw.
45 myelodysplas*.tw.
46 chemotherapy.mp.
47 tumo?r*.mp.
48 carcinom*.mp.
49 or/41‐48
50 exp ANTINEOPLASTIC AGENTS/
51 REMISSION INDUCTION/
52 exp ANTINEOPLASTIC PROTOCOLS/
53 ((consolidat* or induct* or maintenance or conditioning*) and (therap* or treat* or regimen* or patient*)).tw,kf,ot.
54 ((anticancer* or cancer*) adj2 (therap* or treat*)).tw,kf,ot.
55 (remission* adj2 therap*).tw,kf,ot.
56 (remission* adj2 induction*).tw,kf,ot.
57 (chemotherap* or chemo‐therap*).tw,kf,ot.
58 (Antineoplast* or anti‐neoplast*).tw,kf,ot.
59 ((cytosta* or cytotox*) adj2 (therap* or treat* or regimen*)).tw,kf,ot.
60 or/50‐59
61 randomized controlled trial.pt.
62 controlled clinical trial.pt.
63 randomi?ed.ab.
64 placebo.ab.
65 drug therapy.fs.
66 randomly.ab.
67 trial.ab.
68 groups.ab.
69 or/61‐68
70 humans.sh.
71 69 and 70
72 60 and 71
73 24 and 29 and 40
74 73 and 49
75 73 and 60
76 74 or 75
77 76 and 71